Logo do repositório
 
Publicação

Comparison of the efficacy of two protocol treatments in patients with symptomatic disc displacement without reduction : a randomized controlled trial

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorAlmeida, André Mariz de
dc.contributor.authorBotelho, João
dc.contributor.authorMachado, Vanessa
dc.contributor.authorMendes, José João
dc.contributor.authorManso, Cristina
dc.contributor.authorGonzález-López, Santiago
dc.date.accessioned2026-02-10T10:58:55Z
dc.date.available2026-02-10T10:58:55Z
dc.date.issued2023-05
dc.description.abstractThe aim of this study was to compare the effectiveness of arthrocentesis followed by hyaluronic acid infiltration treatment (ASH) and mandibular exercise therapy (MET) in patients with symptomatic disc displacement without reduction (DDwoR) by examining pain intensity (VAS), mandibular range of motion (MO), and quality of life (QoL). Fifty-two patients were randomly allocated into two groups, MET (N = 26) and ASH (N = 26), and therapy was applied at the baseline and one month after. Patients were followed up at 1 and 12 months after the baseline assessment. Clinical and patient-reported outcomes were compared at the baseline, 1-month follow-up, and 12-month follow-up. The study found no significant differences in VAS and MO between the ASH and MET groups at the baseline. However, while not significant, it was noted that the ASH group showed higher values for MO. Regarding OHIP-14 at 1 month of follow-up, the ASH group showed significant improvements in physical pain (p > 0.01), physical and psychological disability (p = 0.043 and p = 0.029), and handicap (p = 0.033). At the 12-month follow-up, the ASH group showed significant improvements in functional limitation, psychological discomfort, psychological disability, and handicap (p = 0.008, p = 0.001, p = 0.001, p = 0.005, respectively). ASH treatment did not reduce pain or improve mandibular range of motion more than physical therapy in patients with symptomatic DDwoR. However, ASH could be preferable given its positive long-term effects on patients’ quality of life. The clinician’s main objective is to prioritize the treatment plan order with a focus on the patient’s quality of life. Accordingly, healthcare professionals should consider ASH as a treatment option for patients with symptomatic DDwoR who desire long-term improvement in their quality of life.eng
dc.identifier.citationde Almeida AM, Botelho J, Machado V, Mendes JJ, Manso C, González-López S. Comparison of the Efficacy of Two Protocol Treatments in Patients with Symptomatic Disc Displacement without Reduction: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023; 12(9):3228. https://doi.org/10.3390/jcm12093228
dc.identifier.doi10.3390/jcm12093228
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10400.26/61592
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relation.hasversionhttps://doi.org/10.3390/jcm12093228
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectarthrocentesis
dc.subjecthyaluronic acid
dc.subjectquality of life
dc.subjecttemporomandibular joint
dc.subjecttemporomandibular joint disorders
dc.subjectmandibular exercises
dc.titleComparison of the efficacy of two protocol treatments in patients with symptomatic disc displacement without reduction : a randomized controlled trialeng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.issue9
oaire.citation.startPage3228
oaire.citation.titleJournal of Clinical Medicine
oaire.citation.volume12
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_JJMendes_2023_03.pdf
Tamanho:
658.87 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: